Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-18-001565.pdf 0000899243-18-001565.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-013431.pdf 0001193125-18-013431.rtf 0001193125-18-013431.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Plesha Scott M. 0000899243-18-000110.pdf 0000899243-18-000110.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-383686.pdf 0001193125-17-383686.rtf 0001193125-17-383686.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-377748.pdf 0001193125-17-377748.rtf 0001193125-17-377748.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-372111.pdf 0001193125-17-372111.rtf 0001193125-17-372111.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-369630.pdf 0001193125-17-369630.rtf 0001193125-17-369630.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-365020.pdf 0001193125-17-365020.rtf 0001193125-17-365020.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Watson W. Mark 0000899243-17-028259.pdf 0000899243-17-028259.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-352478.pdf 0001193125-17-352478.rtf 0001193125-17-352478.xls View HTML

Copyright Morningstar